Rapid-acting Treatments for Pediatric Depression and Suicidality: Where are We Now?

Jennifer B. Dwyer, MD, PhD Co-Director Yale Pediatric Depression Program Assistant Professor, Child Study Center and Dept of Radiology and Biomedical Imaging Yale University

1. Describe the proposed mechanism of action of novel rapid-acting anti-depressant and anti-suicidal pharmacotherapeutics
2. Describe the state of the pediatric evidence base for rapid-acting treatments and to compare it with the adult evidence base
3. Appreciate the unique developmental considerations that apply to testing and implementing novel therapeutics in the pediatric population